Calliditas Therapeutics AB (publ)

CALTNASDAQHealthcare

$40.00

$-0.04(-0.10%)

Market Cap$2.1B

P/E Ratio—

52W High$43.0

52W Low$15.25

Avg Volume8K

Open$40.00

Beta1.46

Overview

Calliditas Therapeutics AB (publ) (CALT) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CALT · as of Apr 24, 2024

Latest filing snapshot

200,000

+0+0.00%vs prior year

Calliditas Therapeutics AB (publ) (CALT) employee data is sourced from the annual SEC 20-F filing. As of 2023, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2023-12-31·Full-time · Global

Total Employees

200,000

Change (1Y)

Growth % (1Y)

+0.00%

Revenue / Employee

$6.0K

Net Income / Employee

$-2.3K

Market Cap

$2.1B

CALT Employee Count

2020 – 2023 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2024-04-24	2023-12-31	200,000	+0	+0.00%
2023-04-26	2022-12-31	200,000	+0	+0.00%
2022-04-27	2021-12-31	200,000	+0	+0.00%
2021-04-27	2020-12-31	200,000	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

CALT

Calliditas Therapeutics AB (publ)YOU

200,000$2.1B #2

DCPH

Deciphera Pharmaceuticals, Inc.

355$2.2B #3

KDNY

Chinook Therapeutics, Inc.

214$2.7B #4

FUSN

Fusion Pharmaceuticals Inc.

DICE Therapeutics, Inc.

71$2.3B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CALT peer comparison

About CALT employees

CALT Employees · Headcount

Calliditas Therapeutics AB (publ) (CALT) employee data is sourced from the annual SEC 20-F filing. As of 2023, Calliditas Therapeutics AB (publ) had 200,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

Calliditas Therapeutics AB (publ) employs 200,000 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $6,034, reflecting the company's operational efficiency.

Calliditas Therapeutics AB (publ)'s workforce increased by 0 (0.00%) in 2023 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Calliditas Therapeutics AB (publ)'s revenue per employee of $6,034 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CALT Employees · 5 questions

As of the latest SEC 20-F filing (2023), Calliditas Therapeutics AB (publ) had 200,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Calliditas Therapeutics AB (publ) employee counthow many employees does Calliditas Therapeutics AB (publ) haveCALT total employees 2023

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2024-04-24